Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)

NCT00789750 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00789750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00789750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2009
Completion date
July 31, 2012
Enrollment
562 (actual)
Sites
141

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus